Lawrence Steinman

Lawrence Steinman is an American neurologist, neuroimmunologist and an academic. He is a Professor of Neurology and Neurological Sciences and Pediatrics at Stanford University.

Steinman's research has focused on how the immune system attacks the brain, specifically in cases of multiple sclerosis (MS), motor neuron disease (ALS), and neuromyelitis optica (NMO). He discovered the target for the first approved MS therapy using a monoclonal antibody and his work has elucidated how the Epstein-Barr virus (EBV) triggers MS. His laboratory at Stanford published research leading to the first approved monoclonal antibody therapy for MS, Natalizumab (Tysabri), and clarified the molecular basis for how EBV triggers MS. He has received awards, including the John Dystel Prize, the Charcot Prize for Lifetime Achievement in MS, and the Cerami Prize for creating a new field of research and contributing to disease prevention and treatment. He has also twice been awarded the Senator Jacob Javits Neuroscience Investigator Award by the National Institute of Neurological Diseases and Stroke.

Steinman is an elected member of the US National Academy of Sciences, and the US National Academy of Medicine. Provided by Wikipedia